Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1725 of 3499 entries
View as:

1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00567931 Org: User:
Start: 10/31/07 End: 09/30/12 Due: 09/30/13

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03748927 Org: User:
Start: 04/08/19 End: 03/23/20 Due: 03/23/21

Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00070447 Org: User:
Start: 11/30/03 End: 06/30/06 Due: 06/30/07

Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002537 Org: User:
Start: 09/30/93 End: - Due: -

Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01696981 Org: User:
Start: 11/16/93 End: 03/25/26 Due: 03/25/27

Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02487095 Org: User:
Start: 07/30/15 End: 12/26/24 Due: 12/26/25

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00019539 Org: User:
Start: 11/30/98 End: 11/30/04 Due: 11/30/05

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00089180 Org: User:
Start: 03/31/04 End: - Due: -

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00946335 Org: User:
Start: 07/31/09 End: 06/30/14 Due: 06/30/15

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

Phase: N/A Priority: Normal
NCT ID: NCT00003789 Org: User:
Start: 03/31/99 End: - Due: -

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02280811 Org: User:
Start: 10/14/14 End: 06/28/16 Due: 06/28/17

Screening for Lung Cancer in Older Patients (PLCO Screening Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01696968 Org: User:
Start: 11/16/93 End: 03/25/26 Due: 03/25/27

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02143414 Org: User:
Start: 06/30/15 End: 10/23/25 Due: 10/23/26

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00001446 Org: User:
Start: 09/30/95 End: 07/31/01 Due: 07/31/02

Vaccine Therapy in Treating Patients With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00003556 Org: User:
Start: 01/31/99 End: - Due: -

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01319539 Org: User:
Start: 04/30/11 End: 07/31/13 Due: 07/31/14

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00107536 Org: User:
Start: 10/31/05 End: 05/31/09 Due: 05/31/10

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00045565 Org: User:
Start: 10/31/02 End: - Due: -

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00334893 Org: User:
Start: 04/30/06 End: 03/31/12 Due: 03/31/13

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01729806 Org: User:
Start: 11/19/12 End: 03/30/18 Due: 03/30/19

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00114257 Org: User:
Start: 05/31/05 End: - Due: -

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01277757 Org: User:
Start: 03/31/11 End: 08/31/14 Due: 08/31/15

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00602043 Org: User:
Start: 09/30/08 End: 09/30/14 Due: 09/30/15

Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00080990 Org: User:
Start: 02/29/04 End: - Due: -

Amatuximab for High Mesothelin Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01413451 Org: User:
Start: 07/12/11 End: 11/15/13 Due: 11/15/14